Similarly, fenebrutinib treatment of patients with rheumatoid arthritis and lupus resulted in greater proportional reductions in rheumatoid factor35 and anti-double-stranded DNA34 compared to total IgM or IgG subclasses, respectively. The gene discussed is CD40LG; the disease is rheumatoid arthritis.